CATALANO, Antonino
 Distribuzione geografica
Continente #
EU - Europa 11.597
NA - Nord America 10.351
AS - Asia 6.129
SA - Sud America 2.042
Continente sconosciuto - Info sul continente non disponibili 611
AF - Africa 183
OC - Oceania 11
Totale 30.924
Nazione #
US - Stati Uniti d'America 10.104
RU - Federazione Russa 6.333
SG - Singapore 2.577
CN - Cina 1.740
BR - Brasile 1.696
IE - Irlanda 1.336
SE - Svezia 1.108
IT - Italia 974
HK - Hong Kong 663
DE - Germania 488
FR - Francia 425
VN - Vietnam 353
FI - Finlandia 220
IN - India 197
GB - Regno Unito 177
PL - Polonia 170
AR - Argentina 124
CA - Canada 105
BD - Bangladesh 100
IQ - Iraq 72
UA - Ucraina 72
MX - Messico 66
EC - Ecuador 65
TR - Turchia 64
NL - Olanda 62
AT - Austria 51
ZA - Sudafrica 49
PK - Pakistan 43
JP - Giappone 39
ES - Italia 38
CO - Colombia 36
ID - Indonesia 36
BE - Belgio 34
VE - Venezuela 32
CL - Cile 30
UZ - Uzbekistan 29
JO - Giordania 25
MA - Marocco 24
PY - Paraguay 23
CI - Costa d'Avorio 22
EG - Egitto 22
PH - Filippine 19
SA - Arabia Saudita 18
MY - Malesia 17
CZ - Repubblica Ceca 16
KR - Corea 15
JM - Giamaica 14
KE - Kenya 14
AZ - Azerbaigian 13
LT - Lituania 13
PE - Perù 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
HN - Honduras 12
IL - Israele 12
NP - Nepal 12
TN - Tunisia 12
CH - Svizzera 11
AU - Australia 10
DO - Repubblica Dominicana 10
DZ - Algeria 9
GT - Guatemala 9
NO - Norvegia 9
BO - Bolivia 8
KG - Kirghizistan 8
RO - Romania 8
BG - Bulgaria 7
CR - Costa Rica 7
ET - Etiopia 7
IR - Iran 7
KZ - Kazakistan 7
NG - Nigeria 7
OM - Oman 7
AL - Albania 6
BH - Bahrain 6
CU - Cuba 6
GR - Grecia 6
SN - Senegal 6
TH - Thailandia 6
EE - Estonia 5
LV - Lettonia 5
GE - Georgia 4
NI - Nicaragua 4
PA - Panama 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
CM - Camerun 3
HU - Ungheria 3
LB - Libano 3
PS - Palestinian Territory 3
RS - Serbia 3
SV - El Salvador 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
DK - Danimarca 2
Totale 30.284
Città #
Moscow 1.732
Ashburn 1.586
Singapore 1.383
Dublin 1.334
Dallas 934
Chandler 911
Hong Kong 622
Nyköping 596
San Jose 581
Beijing 573
Council Bluffs 316
The Dalles 307
Messina 301
Jacksonville 262
Princeton 237
Dearborn 228
Los Angeles 207
Munich 207
New York 207
Lauterbourg 191
Medford 175
Warsaw 156
São Paulo 138
Ann Arbor 136
Ho Chi Minh City 129
Des Moines 127
Cambridge 120
Boardman 108
Bremen 101
Catania 96
Santa Clara 96
Buffalo 88
Turku 76
Redondo Beach 73
Guangzhou 70
Tianjin 68
Jinan 65
Shenyang 65
Wilmington 65
Hanoi 64
Frankfurt am Main 63
Orem 60
Atlanta 57
Pune 50
Houston 49
San Mateo 47
Seattle 45
Belo Horizonte 44
Nanjing 44
Chennai 42
Curitiba 42
Helsinki 41
Rio de Janeiro 41
Milan 38
Brooklyn 36
Nuremberg 35
Brussels 34
Montreal 34
Chicago 32
Porto Alegre 32
Rome 32
Brasília 30
Hebei 30
Tokyo 30
Baghdad 28
London 28
Shanghai 28
Zhengzhou 28
Düsseldorf 27
Johannesburg 27
Vienna 27
Haikou 26
Nanchang 26
Taizhou 26
Amsterdam 25
Boston 25
Hangzhou 25
Strasbourg 25
Ningbo 24
Woodbridge 24
Denver 23
San Francisco 23
Tashkent 23
Abidjan 22
Goiânia 22
Quito 22
Amman 21
Columbus 21
Falls Church 21
Poplar 21
Manchester 20
Guayaquil 19
Hyderabad 19
Lancaster 19
Mexico City 19
Mumbai 18
Toronto 18
Phoenix 17
Stockholm 17
Changsha 16
Totale 16.539
Nome #
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 301
Anxiety levels as risk factor for osteoporosis in postmenopausal women 279
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 272
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 267
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 257
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 244
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 232
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 230
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 228
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 224
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 222
A minimum of two years of undertreated primary hypothyroidism, as a result of drug-induced malabsorption of L-thyroxine, may have metabolic and cardiovascular consequences 222
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 221
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 218
AB0820 COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY 217
A clinical bridge between family caregivers and older adults: The contribution of patients’ frailty and optimism on caregiver burden 216
Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus 215
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 209
ASSOCIATION BETWEEN COGNITIVE IMPULSIVITY AND BONE MINERAL DENSITY: A CROSS-SECTIONAL STUDY IN POSTMENOPAUSAL WOMEN EVALUATED FOR OSTEOPOROSIS 209
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 204
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 202
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 202
Association between cognitive reserve dimensions and frailty among older adults: A structured narrative review 199
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 195
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 194
Multiple osteoporotic fractures complicating Wolfram syndrome 193
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 193
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 192
Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density 191
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 191
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 189
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 188
Hyponatremia as a leading sign of hypopituitarism 187
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 185
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 185
Clinical psychological evaluation in elderly men with prostatic hypertrophy in treatment with Dutasteride. 185
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 182
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 177
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 174
Association between anxiety levels and osteoporosis in postmenopausal women. 174
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 172
Alexithymia and asthma: a systematic review 172
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 171
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 170
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 170
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 169
Incidence of Hypocalcemia and Hypercalcemia in Elderly Hospitalized Patients 168
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 168
Effects of genistein aglycone in glucocorticoid induced osteoporosis: A randomized clinical trial in comparison with alendronate 167
Evidenze dell'uso della vitamina D in pazienti in età molto avanzata 167
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 167
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 166
Frailty and lipid profile in elderly hospitalized patients 166
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 165
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 165
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 164
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 160
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 160
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 160
Postprandial Hypotension and Impaired Postprandial Sustained and Selective Attention in Older Inpatients: Is There a Link? 159
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 159
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 159
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 159
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 159
Frailty modifications and prognostic impact in older patients admitted in acute care 157
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 156
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 156
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 156
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 155
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 154
Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. 154
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 154
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 153
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 153
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 151
A single bone lesion in a man with prostate cancer: a case report of Paget’s disease of bone 150
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 150
Relationship between blood pressure and frailty in older hypertensive outpatients 149
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 149
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 148
Handgrip and phalangeal quantitative ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis. 148
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 148
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 147
Estimating glomerular filtration rate in centenarians: comparison of the chronic kidney disease epidemiology collaboration (CKD-EPI) and modification of diet in renale disease (MDRD) study equation 146
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 146
Seroprevalence of hepatitis B virus and hepatitis C virus infections in elderly residents in nursing homes in Southern Italy 146
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 145
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 145
Does vitamin D3 have an impact on clinical and biochemical parameters related to third molar surgery 145
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 145
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 145
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 144
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 143
Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach 143
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 142
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 142
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 141
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 141
VASCULAR CALCIFICATIONS ARE RELATED TO SCLEROSTIN AND DICKKOPF-1 IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 141
Early vascular ageing biomarkers in osteoporotic outpatients: a pilot study 141
Totale 17.756
Categoria #
all - tutte 101.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.554 0 134 23 60 43 22 150 52 152 298 124 496
2022/20233.707 277 378 179 232 298 332 36 178 1.597 48 115 37
2023/20241.116 76 160 54 127 77 246 37 93 4 41 31 170
2024/20254.890 85 73 94 333 244 166 131 931 1.159 372 440 862
2025/202615.198 783 1.049 1.010 1.035 1.304 3.032 1.818 2.042 1.932 655 240 298
2026/20271.571 356 1.215 0 0 0 0 0 0 0 0 0 0
Totale 30.924